Clinical Trial Update: The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound [Phase 4]

View source ↗

Summary

This entry reports on a Phase 4 clinical trial evaluating an ionic silver dressing for head and neck cancer patients with malignant fungating wounds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Ionic silver dressing (silver dressing)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Head and Neck Neoplasms, Head and Neck Cancer | Phase 4 | Status: UNKNOWN